Targeted agents in epithelial ovarian cancer: review on emerging therapies and future developments

Epithelial ovarian cancer (EOC) remains a clinical challenge and there is a need to optimise the currently available treatment and to urgently develop new therapeutic strategies. Recently, there has been improved understanding of the molecular characteristics and tumour microenvironment of ovarian c...

Descripción completa

Detalles Bibliográficos
Autores principales: Lokadasan, Rajitha, James, Francis V, Narayanan, Geetha, Prabhakaran, Pranab K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817523/
https://www.ncbi.nlm.nih.gov/pubmed/27110282
http://dx.doi.org/10.3332/ecancer.2016.626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817523/
https://www.ncbi.nlm.nih.gov/pubmed/27110282
http://dx.doi.org/10.3332/ecancer.2016.626

Ejemplares similares